Author:
El-Shemi Adel Galal,Ashshi Ahmad Mohammed,Na Youjin,Li Yan,Basalamah Mohammed,Al-Allaf Faisal Ahmad,Oh Eonju,Jung Bo-Kyeong,YUN Chae-Ok
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Jiang G, Zhang L, Zhu Q, Bai D, Zhang C, Wang X. CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma. J Exp Clin Cancer Res. 2016;35(1):38.
2. Stotz M, Gerger A, Haybaeck J, Kiesslich T, Bullock MD, Pichler M. Molecular targeted therapies in hepatocellular carcinoma: past, present and future. Anticancer Res. 2015;35(11):5737–44.
3. Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H. The efficacy of continued Sorafenib treatment after radiologic confirmation of progressive disease in patients with advanced hepatocellular carcinoma. PLoS One. 2016;11(1):e0146456.
4. Bhayani NH, Jiang Y, Hamed O, Kimchi ET, Staveley-O’Carroll KF, Gusani NJ. Advances in the pharmacologic treatment of hepatocellular carcinoma. Curr Clin Pharmacol. 2015;10(4):299–304.
5. Larson C, Oronsky B, Scicinski J, Fanger GR, Stirn M, Oronsky A, Reid TR. Going viral: a review of replication-selective oncolytic adenoviruses. Oncotarget. 2015;6(24):19976–89.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献